Skip to main content
Fig. 8 | Surgical Case Reports

Fig. 8

From: Central pancreatic body-preserving pancreatoduodenectomy for pancreatic head cancer following a combined total gastrectomy and distal pancreatectomy: a case report

Fig. 8

The transition of the tumor markers and HbA1c levels during treatment. A graphical representation of the transition of both carcinoembryonic antigen and CA 19–9 levels along with that of the glycosylated hemoglobin values, indicating a recurrence of peritoneal dissemination 12 months after the surgery, following which, chemotherapy was resumed. CEA, carcinoembryonic antigen; HbA1c, glycosylated hemoglobin; S-1, tegafur, gimeracil, and oteracil potassium; NACRT, neo-adjuvant chemoradiotherapy; GEM+nabPTX, chemotherapy with Gemcitabine and nab-paclitaxel

Back to article page